Thierry Vernier
Director/Board Member presso Bioverativ Therapeutics, Inc.
Profilo
Thierry Vernier is currently a Director at Bioverativ Therapeutics, Inc. He previously worked as a Vice President-Financial Control & Plan at Sanofi from 2004 to 2013.
He is a graduate of Ecole de Management de Normandie.
Posizioni attive di Thierry Vernier
| Società | Posizione | Inizio |
|---|---|---|
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Director/Board Member | - |
Precedenti posizioni note di Thierry Vernier
| Società | Posizione | Fine |
|---|---|---|
| SANOFI | Comptroller/Controller/Auditor | 21/06/2012 |
Formazione di Thierry Vernier
| Ecole de Management de Normandie | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SANOFI | Commercial Services |
| Aziende private | 1 |
|---|---|
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Thierry Vernier
